公开(公告)号：US20170091380A1

公开(公告)日：2017-03-30

申请号：US15197172

申请日：2016-06-29

申请人： OPKO Diagnostics, LLC ,  OY Arctic Partners Ab

发明人： Andrew J. Vickers ,  Peter T. Scardino ,  Hans Lilja ,  Vincent Linder ,  David Steinmiller

IPC分类号： G06F19/18 ,  C12Q1/68 ,  G01N33/543 ,  G06F19/00 ,  G06F19/24

CPC分类号： G16B20/00 ,  B01L3/502 ,  B01L3/502715 ,  B01L3/502761 ,  B01L2300/0654 ,  B01L2300/0816 ,  B01L2300/087 ,  B01L2400/0487 ,  C12Q1/6886 ,  C12Q2600/112 ,  C12Q2600/158 ,  C12Q2600/16 ,  G01N33/54366 ,  G01N33/57434 ,  G01N33/6893 ,  G01N2333/96455 ,  G16B40/00 ,  G16H10/40 ,  G16H50/20 ,  G16H50/30

摘要： Methods and apparatuses for conducting analyses are provided.

公开(公告)号：US09672329B2

公开(公告)日：2017-06-06

申请号：US13785058

申请日：2013-03-05

申请人： Oy Arctic Partners Ab ,  OPKO Diagnostics, LLC

发明人： Andrew J. Vickers ,  Peter T. Scardino ,  Hans Lilja ,  Vincent Linder ,  David Steinmiller

IPC分类号： G01N33/48 ,  G06F19/00 ,  G06F19/18 ,  G06F19/24 ,  B01L3/00 ,  G01N33/68 ,  G06G7/48

CPC分类号： G06F19/18 ,  B01L3/502 ,  B01L3/502715 ,  B01L3/502761 ,  B01L2300/0654 ,  B01L2300/0816 ,  B01L2300/087 ,  B01L2400/0487 ,  C12Q1/6886 ,  C12Q2600/112 ,  C12Q2600/158 ,  C12Q2600/16 ,  G01N33/54366 ,  G01N33/57434 ,  G01N33/6893 ,  G01N2333/96455 ,  G06F19/00 ,  G06F19/24 ,  G16H10/40 ,  G16H50/20 ,  G16H50/30

摘要： Methods and apparatuses for predicting risk of prostate cancer and/or prostate gland volume are provided. More particularly, this disclosure relates to methods and apparatuses for providing the models and employing the models for predicting risk of prostate cancer and/or predicting prostate gland volume. The methods and apparatuses for predicting risk of prostate cancer and/or prostate gland volume are provided using, at least in part, information from a panel of kallikrein markers.

公开(公告)号：US10672503B2

公开(公告)日：2020-06-02

申请号：US15197148

申请日：2016-06-29

申请人： OPKO Diagnostics, LLC ,  Oy Arctic Partners Ab

发明人： Andrew J. Vickers ,  Peter T. Scardino ,  Hans Lilja ,  Vincent Linder ,  David Steinmiller

IPC分类号： G01N33/48 ,  G16B20/00 ,  G16H10/40 ,  G16B40/00 ,  B01L3/00 ,  G01N33/68 ,  G16H50/30 ,  C12Q1/6886 ,  G01N33/543 ,  G16H50/20 ,  G01N33/574 ,  G06G7/58

摘要： Methods and apparatuses for conducting analyses are provided.

公开(公告)号：US20170168060A1

公开(公告)日：2017-06-15

申请号：US15443102

申请日：2017-02-27

申请人： OPKO Diagnostics, LLC ,  Oy Arctic Partners Ab

发明人： Andrew J. Vickers ,  Peter T. Scardino ,  Hans Lilja ,  Vincent Linder ,  David Steinmiller

IPC分类号： G01N33/574 ,  G06F19/24 ,  B01L3/00 ,  G06F19/00

CPC分类号： G16B20/00 ,  B01L3/502 ,  B01L3/502715 ,  B01L3/502761 ,  B01L2300/0654 ,  B01L2300/0816 ,  B01L2300/087 ,  B01L2400/0487 ,  C12Q1/6886 ,  C12Q2600/112 ,  C12Q2600/158 ,  C12Q2600/16 ,  G01N33/54366 ,  G01N33/57434 ,  G01N33/6893 ,  G01N2333/96455 ,  G16B40/00 ,  G16H10/40 ,  G16H50/20 ,  G16H50/30

摘要： Methods and apparatuses for predicting risk of prostate cancer and/or prostate gland volume are provided. More particularly, this disclosure relates to methods and apparatuses for providing the models and employing the models for predicting risk of prostate cancer and/or predicting prostate gland volume. The methods and apparatuses for predicting risk of prostate cancer and/or prostate gland volume are provided using, at least in part, information from a panel of kallikrein markers.

公开(公告)号：US12131802B2

公开(公告)日：2024-10-29

申请号：US15443102

申请日：2017-02-27

申请人： OPKO Diagnostics, LLC ,  Oy Arctic Partners Ab

发明人： Andrew J. Vickers ,  Peter T. Scardino ,  Hans Lilja ,  Vincent Linder ,  David Steinmiller

IPC分类号： G16B20/00 ,  B01L3/00 ,  C12Q1/6886 ,  G01N33/543 ,  G01N33/574 ,  G01N33/68 ,  G16B40/00 ,  G16H10/40 ,  G16H50/20 ,  G16H50/30

CPC分类号： G16B20/00 ,  B01L3/502 ,  B01L3/502715 ,  B01L3/502761 ,  C12Q1/6886 ,  G01N33/54366 ,  G01N33/57434 ,  G01N33/6893 ,  G16B40/00 ,  G16H10/40 ,  G16H50/20 ,  G16H50/30 ,  B01L2300/0654 ,  B01L2300/0816 ,  B01L2300/087 ,  B01L2400/0487 ,  C12Q2600/112 ,  C12Q2600/158 ,  C12Q2600/16 ,  G01N2333/96455

摘要： Methods and apparatuses for predicting risk of prostate cancer and/or prostate gland volume are provided. More particularly, this disclosure relates to methods and apparatuses for providing the models and employing the models for predicting risk of prostate cancer and/or predicting prostate gland volume. The methods and apparatuses for predicting risk of prostate cancer and/or prostate gland volume are provided using, at least in part, information from a panel of kallikrein markers.